Pruebas
Double-Negative Myeloid Dendritic Cell Count
The determination of the amount of double-negative myeloid dendritic cells (any myeloid dendritic cell that is both CD1c-CD141-) present in a sample.
Loading
Loading
Busque productos, empresas, pruebas y guías: pase de la consulta a la solicitud de cotización en un solo lugar.
Pruebas
The determination of the amount of double-negative myeloid dendritic cells (any myeloid dendritic cell that is both CD1c-CD141-) present in a sample.
Pruebas
The determination of the amount of myeloid dendritic cells present in a sample.
Pruebas
A measurement of the type 1 myeloid dendritic cells in a sample.
Pruebas
A BCR-ABL1 genetic test uses a sample of blood or bone marrow to look for an abnormal gene called BCR-ABL1. This abnormal gene is found in certain types of blood cancer , such as chronic myeloid leukemia (CML).
Pruebas
The determination of the amount of CD33 expressing cells per unit present in a sample.
Pruebas
The determination of the amount of CCL23, chemokine (C-C motif) ligand 23, present in a sample.
Pruebas
The determination of the ratio of monocytes classic to myeloid cells present in a sample. The measurement may be expressed as a ratio or percentage.
Pruebas
The determination of the ratio of dendritic cells to myeloid cells present in a sample. The measurement may be expressed as a ratio or percentage.
Pruebas
The determination of the number of double-negative myeloid-derived suppressor cells (any MDSC that is both CD14- and CD15-) present in a sample.
Pruebas
The determination of the ratio of a sub-population of double-negative myeloid-derived suppressor cells to all double-negative myeloid-derived suppressor cells present in a sample. The measurement may be expressed as a ratio or percentage.
Pruebas
The determination of the ratio of the double negative myeloid-derived suppressor cells to all myeloid-derived suppressor cells present in a sample. The measurement may be expressed as a ratio or percentage.
Pruebas
The determination of the number of a sub-population of double-negative myeloid-derived suppressor cells present in a sample.